Literature DB >> 9166948

Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.

H Tsuda1, C Sakamaki, T Fukutomi, S Hirohashi.   

Abstract

Although breast carcinomas are considered to originate from glandular epithelial cells, some exhibit 'squamoid features', comprising stratification with a gradient in the nuclear-cytoplasmic ratio within individual cancer cell nests on microscopy. In parallel with a histological review of squamoid features, we immunohistochemically investigated the expression of involucrin, a marker of terminal squamous differentiation, in 223 breast carcinomas with one to three regional nodal metastases but no distant metastases and analysed their association with other clinicopathological parameters to explore their clinical and biological implications. Squamoid features and involucrin expression, detected in 22% and 27% of cases respectively, correlated with each other and were associated with high-grade atypia, a solid-nest pattern, cancer cell necrosis on histology and negative oestrogen receptor status. The incidence of regional recurrences was higher in patients with involucrin expression, whereas bone metastases were less frequent in groups with squamoid features or with diffuse (> or = 10%) involucrin expression. Both squamoid features and involucrin expression, which were considered to be derived either from differentiation into keratinocytes or from some kind of cellular degeneration caused by high turnover rate, are suggested to influence the biological behaviour of breast cancer cells in vivo, and they may be effective in predicting the most likely recurrence sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166948      PMCID: PMC2223517          DOI: 10.1038/bjc.1997.260

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. A retrospective analysis of 176 cases.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; S Watanabe; M Terada; H Yamamoto
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

2.  Involucrin expression in breast carcinomas: an immunohistochemical study.

Authors:  C Schmid; K Zatloukal; A Beham; H Denk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

3.  Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases.

Authors:  Z Bouizar; F Spyratos; S Deytieux; M C de Vernejoul; A Jullienne
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

Review 4.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

5.  Apoptosis in breast cancer as related to histopathological characteristics and prognosis.

Authors:  P Lipponen; S Aaltomaa; V M Kosma; K Syrjänen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

6.  The characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating protein.

Authors:  A M Lynley; B A Dale
Journal:  Biochim Biophys Acta       Date:  1983-04-14

7.  Immunoperoxidase staining for involucrin: a potential diagnostic aid in cervicovaginal pathology.

Authors:  M J Warhol; D A Antonioli; G S Pinkus; L Burke; R H Rice
Journal:  Hum Pathol       Date:  1982-12       Impact factor: 3.466

8.  Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation.

Authors:  G F Murphy; T C Flynn; R H Rice; G S Pinkus
Journal:  J Invest Dermatol       Date:  1984-05       Impact factor: 8.551

9.  Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.

Authors:  C Kamby; J Andersen; B Ejlertsen; N E Birkler; L Rytter; K Zedeler; S M Thorpe; T Nørgaard; C Rose
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

10.  Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; Y Tanaka; T Hirota; S Tsugane; M Shiraishi; K Toyoshima; T Yamamoto; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-04
View more
  5 in total

1.  Pleomorphic carcinoma of the breast in a 17-year-old woman.

Authors:  Rin Yamaguchi; Maki Tanaka; Miki Yamaguchi; Takanaru Fukushima; Yuko Kaneko; Hiroko Otsuka; Shin Isobe; Hiroshi Terasaki; Osamu Nakashima; Masayoshi Kage; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

2.  Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.

Authors:  Rin Yamaguchi; Maki Tanaka; Keiko Kondo; Toshiro Yokoyama; Ichiro Maeda; Shin-Ichi Tsuchiya; Miki Yamaguchi; Ryuji Takahashi; Yutaka Ogata; Hideyuki Abe; Jun Akiba; Osamu Nakashima; Masayoshi Kage; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

3.  Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast.

Authors:  T Koyama; T Hasebe; H Tsuda; S Hirohashi; S Sasaki; T Fukutomi; S Imoto; T Umeda; K Mukai
Journal:  Jpn J Cancer Res       Date:  1999-03

4.  Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.

Authors:  Arvind Bambhroliya; Renae D Van Wyhe; Swaminathan Kumar; Bisrat G Debeb; Jay P Reddy; Steve Van Laere; Randa El-Zein; Arvind Rao; Wendy A Woodward
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

5.  Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.

Authors:  Renjian Xie; Bifei Li; Lee Jia; Yumei Li
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.